High-Resolution Mass Spectrometry top 20

High-Resolution Mass Spectrometry

What is Characterization of Biologics?

Characterization of biologics plays an important role in the development of Biopharmaceuticals, such as monoclonal antibodies, fusion proteins, antibody drug conjugates, biosimilars etc. Characterization is the analysis of biologics to understand the primary, secondary, tertiary, and other higher order structure using physicochemical, biophysical and biological methods. During biologics drug development process, physicochemical, biophysical and biological properties can have an impact on the product's performance and safety.

 

Why characterize Biologics?

According to ICH Q6B guidelines, biologics characterization is the essential part of the successful development of bio-pharmaceuticals. In-depth knowledge of biologics and their chemistry, structure, and biological activities facilitates smoother process design to ensure the drug to attain critical product safety, purity, and potency.

 

Characterization and analysis of Biologics and Biosimilars requires highly sophisticated analytical workflows with significant emphasis on GMP and regulatory compliance. Development of both originator biotherapy and biosimilar products requires thorough characterization to ensure robust and well specified biological drug. Characterization of biologics includes identity testing, analysis of post translational modifications (PTM), physical testing, size distribution, analysis, sterility testing, impurities, etc.

 

Our laboratories are well equipped with broad analytical technologies and our expertise in high end mass spectrometry (Orbitrap and QToF) analysis allows us the ability to provide High-Resolution Accurate-Mass (HRAM) data, that meets cGLP, cGMP and regulatory requirements.

 

Crystal biotech, founded in 2010, is a global contract research organization with approximately 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Crystal Pharmatech is a leading pharma tech CRO/CDMO company specializing in solid-state research and advanced formulation development for small molecule drugs.

 

As a cdmo pharma company, we will do our best to meet all the needs of customers.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Founded in 2010, Crystal Pharmatech has been providing the world-leading solid state research, and formulation CDMO services to global pharmaceutical companies. We use Molecule-Material-Medicine (MMM) approach to develop the best crystal and formulation for your molecules. Over the last 11 years, we have supported over 800 global pharmaceutical companies on more than 1500 drug molecules through our innovative technology and solid science in solid state research and formulation. We look forward to partnering with you together to accelerate your drug development and create a healthier world. https://www.crystalpharmatech.com/